Login

Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Assets:
Current assets:
Cash
Prepaid expenses
Total current assets
Cash and investments held in Trust Account
Total Assets
Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit:
Current liabilities:
Accounts payable
Accrued expenses
Franchise tax payable
Income tax payable
Due to related party
Excise tax payable
Convertible promissory note, at fair value
Working capital loan - related party, at fair value
Total current liabilities
Derivative warrant liabilities
Deferred underwriting commissions in connection with the initial public offering
Total Liabilities
Class A common stock. $0.0001 par value; 7,135,509 and 22,233,687 shares subject to possible redemption at redemption value of approximately $10.43 and $10.10 per share as of June 30, 2023 and December 31, 2022, respectively
Stockholders’ Deficit:
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; no non-redeemable shares issued or outstanding at June 30, 2023 and December 31, 2022
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 5,558,422 shares issued and outstanding at June 30, 2023 and December 31, 2022
Additional paid-in capital
Accumulated deficit
Total stockholders’ deficit
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support